Top Markets
Coin of the day
Entia Biosciences, Inc. Entia Biosciences, Inc.

Entia Biosciences, Inc.

ERGO
Rankning i aktier #41967
Entia Biosciences, Inc. engages in the development, production, and... Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.
Aktiekurs
$0.0002
Senast synkroniserad: 2026-08-11
Marknadsvärde
$6.73K
Förändring (1 dag)
0.00%
Förändring (1 år)
100.00%
Land
US
Handel Entia Biosciences, Inc. (ERGO)

Kategori

Utdelningsavkastning för Entia Biosciences, Inc. (ERGO)
Utdelningsavkastningen (TTM) för Entia Biosciences, Inc. (aktiesymbol: ERGO) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Entia Biosciences, Inc. (ERGO) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter